Skip to main content
Clinical Trials/NCT01854164
NCT01854164
Completed
Not Applicable

An 8 Weeks, Randomized, Double-blind, Placebo-controlled Clinical Trial for Anti-diabetic Effects of Hydrolyzed Ginseng Extract

Chonbuk National University Hospital1 site in 1 country20 target enrollmentJune 2009
ConditionsHyperglycemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperglycemia
Sponsor
Chonbuk National University Hospital
Enrollment
20
Locations
1
Primary Endpoint
Changes of blood glucose during OGTT(oral glucose tolerance test)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study was conducted to investigate the effects of daily supplementation of hydrolyzed ginseng extract(HGE) on glycemic status in subjects with impaired fasting glucose(IFG).

Detailed Description

This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Twenty subjects were randomly divided into HGE or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
December 2009
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 20-70 years with fasting glucose 100\~126 mg/dL

Exclusion Criteria

  • Abnormal lipid profile values
  • Acute/chronic inflammation
  • Treated with corticosteroid within past 4 weeks
  • Cardiovascular disease
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of disease that could interfere with the test products or impede their absorption
  • Participation in any other clinical trials within past 2 months
  • Renal disease
  • Abnormal hepatic function
  • Under hypolipidemic drugs therapy within past 3 months

Outcomes

Primary Outcomes

Changes of blood glucose during OGTT(oral glucose tolerance test)

Time Frame: 8 weeks

Changes of fasting and postprandial glucose during OGTT were assessed before(baseline) and after the intervention.

Secondary Outcomes

  • Changes of blood insulin during OGTT.(8 weeks)
  • Changes of glycated albumin, fructosamine, and lipid profile(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials